GAM
CLVS

Gemmer Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Gemmer Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-189
Closed -$7K – 1257
2016
Q3 		$7K Hold
189
– – ﹤0.01% 791
2016
Q2 		$3K Hold
189
– – ﹤0.01% 1100
2016
Q1 		$3K Hold
189
– – ﹤0.01% 1002
2015
Q4 		$7K Buy
189
+128
+210% +$8.26K ﹤0.01% 727
2015
Q3 		$6K Hold
61
– – ﹤0.01% 775
2015
Q2 		$5K Buy
+61
New +$5.22K ﹤0.01% 880

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PointState Capital
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Gemmer Asset Management's CLVS Position: Q4 2016 in Review

Gemmer Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2016, closing a stake of 189 shares — an estimated $7K sold.

Gemmer Asset Management first reported a position in CLVS in Q2 2015 and held it in 6 quarters. The position peaked at $7K in Q3 2016. 167 funds tracked by Wall St. Rank hold CLVS as of Q4 2016.

  • Gemmer Asset Management reported no remaining Clovis Oncology, Inc. position as of Q4 2016 after selling out during the quarter.
  • Gemmer Asset Management sold 189 Clovis Oncology, Inc. shares in Q4 2016, an estimated $7K.
  • Gemmer Asset Management first reported a position in Clovis Oncology, Inc. in Q2 2015 and held it in 6 quarters.
  • Gemmer Asset Management's Clovis Oncology, Inc. position peaked at $7K in Q3 2016.
  • 167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2016.

Based on Gemmer Asset Management's 13F filing for Q4 2016, filed 13 Jan 2017.